In the late 1990's, GlaxoSmithKline ("GSK") conducted three clinical studies on the efficacy of PAXIL for children and adolescents. One study showed mixed results, while the other two studies failed to show any effectiveness for the treatment of childhood depression. In fact, one of the failed studies indicated that PAXIL was less effective than placebo (a sugar pill). GSK then published the study with mixed results and withheld the other studies from regulatory authorities, doctors, and the general public.

In an internal 1998 memo, GSK admits that its "TARGET" was "To effectively manage the dissemination of these data in order to minimize any potential negative commercial impact" and that "it would be commercially unacceptable to include a statement that efficacy had not been demonstrated, as this would undermine the profile of [Paxil]." Not until pressure from European regulatory authorities did GSK make a label change informing the public that PAXIL was ineffective and not to be used in patients under the age of 18. However, this action was taken only in Europe and still today GSK has not taken any affirmative steps to make this same change in the United States. In 2002, there were 10 million anti-depressant prescriptions for children ages 1-17 years of age in the United States, and approximately 2.2 million of those were written for PAXIL.

In August of 2004, a class action lawsuit by the Minneapolis law firm of Meshbesher & Spence, Ltd. was filed seeking reimbursement for purchases of PAXIL by children and their families based upon GSK's fraud and misrepresentation. If your child took Paxil, and you are interested in being part of the class action, or if you are just seeking information, please fill in our form on the right to submit your complaint. There are statutes of limitations governing these claims, and so you should act promptly to protect your rights.

If your injustice does not match the complaint described above, please use this form to register your complaint. Thank you.


Reader Comments

Posted by

Son born 5 weeks early with complications. Spent 8-9 day in Akrons Childrens Unit at St. Eve Hospital.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help